The misuse of antibiotics in farmed animals is on the radar of EU citizens across countries and sociodemographic groups. There is high awareness and it’s perceived as quite risky for food safety, especially among those responsive to risk communication. This provides a good basis for the effectiv...
Antimicrobial resistance (AMR) is recognised as a significant and challenging global phenomenon. The European Commission has been at the forefront in developing and supporting strategies to fight this threat. The collection and analysis of reliable and comparable data is crucial to understand tr...
The results presented in this report are based on antimicrobial resistance data from invasive isolates reported to EARS-Net by 30 European Union (EU) and European Economic Area (EEA) countries in 2017 (data referring to 2016), and on trend analyses of data reported by the participating countries...
The research is the key to the fight against Antimicrobial Resistance, but funding against the AMR in Europe is not acceptable because of the magnitude of the heath problem. In this context, in Andalusia (Spain), the PIRASOA Programme has been successfully implemented and developed, integrated i...
Antimicrobial resistance (AMR) is a growing threat to global health. The EU follows a ‘One Health’ approach to the problem, considering veterinary, human health, and environmental issues. We examined how the Commission and relevant EU agencies managed their support to Member States and the EU fu...
In March 2019, the Commission adopted the European Union Strategic Approach to Pharmaceuticals in the Environment (PiE) which focuses on actions to address the environmental implications of all phases of the lifecycle of (both human and veterinary) pharmaceuticals, from design and production thr...
